Inflammation is a key component of the initiation and progression of diseases such as DMD, thus, activating the integrated signalling network involving Nrf2, NF-κB and HO-1 is a logical approach in DMD treatment. This evidence concerns the gene HMOX1 and Duchenne muscular dystrophy.